The World Health Organization estimated that during 2019, 58 million people worldwide were living with the Hepatitis C virus (HCV) which causes inflammation of the liver. All types of hepatitis can be controlled or prevented. There is a cure for Hepatitis C; however, HCV infection is often undiagnosed because it remains asymptomatic until symptoms appear that are related to serious liver damage, a complication of the infection.
This educational podcast activity is brought to you by Ortho Clinical Diagnostics, Inc., and is not certified for continuing medical education. Ortho Clinical Diagnostics, Inc. sponsors the program, and the speaker must present information following applicable FDA requirements.
Medical Director of the Molecular Diagnostics Laboratory and Assistant Professor of Pathology & Immunology at Washington University
St. Louis, MO
Dr. Bijal Parikh is the Medical Director of the Molecular Diagnostics Laboratory and Assistant Professor of Pathology & Immunology at Washington University in St. Louis, Missouri.
He is the author of numerous publications with his clinical research centered on aspects of laboratory testing involving viral, immunologic, and molecular diagnostics, with a specific focus on the implementation of next-generation sequencing approaches. Recently, Dr. Parikh authored an article published in Clinical Microbiology Newsletter titled Laboratory Strategies for Diagnosis and Monitoring of Hepatitis C Virus Infection.
Parikh, B. Laboratory Strategies for Diagnosis and Monitoring of Hepatitis C Virus Infection. Clinical Microbiology Newsletter. Nov. 2021. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0196439921000702
https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
